(BUSINESS WIRE)--VIRxSYS -- WHAT: VIRxSYS to present data on its first clinical trial using lentiviral vectors in a presentation entitled Findings from Phase I/II and decisions regarding next step. The presentation will address the following:
(BUSINESS WIRE)--VIRxSYS -- WHAT: VIRxSYS to present data on its first clinical trial using lentiviral vectors in a presentation entitled Findings from Phase I/II and decisions regarding next step. The presentation will address the following:
